![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|21|10|1201-1211
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.21, Iss.10, 2014-04, pp. : 1201-1211
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuroprotective agents in traumatic brain injury
By Maas A.I.
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adenosine Neuromodulation and Traumatic Brain Injury
Current Neuropharmacology, Vol. 7, Iss. 3, 2009-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Biomarkers in Silent Traumatic Brain Injury
Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bridge Between Neuroimmunity and Traumatic Brain Injury
Current Pharmaceutical Design, Vol. 20, Iss. 26, 2014-08 ,pp. :